FDA Inspection 1318396 — Chloe A. Cunningham, FRACP, PhD
The FDA completed an inspection of Chloe A. Cunningham, FRACP, PhD on May 7, 2026 in Parkville. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Parkville (Australia)
Additional Details
Clinical Investigator (CI)